Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Cass

Showing results (271-280 of 289) with videos related to

Pageof 29
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|May 11, 2013
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trialSteven D Weisbord, Martin Gallagher, James Kaufman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 15, 2016
Progression of Kidney Disease in Indigenous Australians: The eGFR Follow-up StudyLouise J Maple-Brown, Jaquelyne T Hughes, Rebecca Ritte, et al.
The Journal of Vascular Access|June 10, 2022
A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trialRebecca Hudson, Elaine M Pascoe, Yong Pey See, et al.
International Journal of Cardiology|October 23, 2013
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE CollaborationRuth Webster, Anushka Patel, Laurent Billot, et al.
Canadian Journal of Kidney Health and Disease|August 20, 2025
Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort StudyElizabeth L M Barr, Federica Barzi, Phillip Mills Kulkalgal, et al.
Redox Report : Communications in Free Radical Research|June 18, 2015
The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trialLei Zhang, Jeff Coombes, Elaine M Pascoe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 18, 2013
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysisBhadran Bose, Sunil V Badve, Swapnil S Hiremath, et al.
Trials|December 3, 2021
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trialSandawana William Majoni, Jane Nelson, Darren Germaine, et al.
BMC Public Health|February 20, 2010
Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR studyLouise J Maple-Brown, Paul D Lawton, Jaquelyne T Hughes, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2015
Research Priorities in CKD: Report of a National Workshop Conducted in AustraliaAllison Tong, Sally Crowe, Shingisai Chando, et al.
Pageof 29

Showing results (271-280 of 289) with videos related to

Sort By:
Pageof 29
Clinical Journal of the American Society of Nephrology : CJASN|May 11, 2013
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trialSteven D Weisbord, Martin Gallagher, James Kaufman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 15, 2016
Progression of Kidney Disease in Indigenous Australians: The eGFR Follow-up StudyLouise J Maple-Brown, Jaquelyne T Hughes, Rebecca Ritte, et al.
The Journal of Vascular Access|June 10, 2022
A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trialRebecca Hudson, Elaine M Pascoe, Yong Pey See, et al.
International Journal of Cardiology|October 23, 2013
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE CollaborationRuth Webster, Anushka Patel, Laurent Billot, et al.
Canadian Journal of Kidney Health and Disease|August 20, 2025
Cardiometabolic Biomarkers and Prediction of Kidney Disease Progression: The eGFR Cohort StudyElizabeth L M Barr, Federica Barzi, Phillip Mills Kulkalgal, et al.
Redox Report : Communications in Free Radical Research|June 18, 2015
The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trialLei Zhang, Jeff Coombes, Elaine M Pascoe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 18, 2013
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysisBhadran Bose, Sunil V Badve, Swapnil S Hiremath, et al.
Trials|December 3, 2021
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis-a protocol for a prospective open-label blinded endpoint randomised controlled trialSandawana William Majoni, Jane Nelson, Darren Germaine, et al.
BMC Public Health|February 20, 2010
Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR studyLouise J Maple-Brown, Paul D Lawton, Jaquelyne T Hughes, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2015
Research Priorities in CKD: Report of a National Workshop Conducted in AustraliaAllison Tong, Sally Crowe, Shingisai Chando, et al.
Pageof 29